BillionToOne Cash Flow Statement
NASDAQ: BLLNHealth CareMedical SpecialitiesUSD
98.09+2.68 (+2.81%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BillionToOne free cash flow
In fiscal 2025, BillionToOne generated $24.6 million of operating cash flow and spent $8.9 million on capital expenditures. That left free cash flow of $15.7 million, a free-cash-flow margin of 5.2% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
BillionToOne cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Net Income | 7.45M | -41.57M | -82.68M |
| Net Income growth (YoY) | — | — | — |
| Depreciation & Amortization | 6.90M | 7.00M | 5.90M |
| Stock-Based Compensation | 15.91M | 8.36M | 4.85M |
| Change in Working Capital | -24.31M | -16.45M | 1.79M |
| Operating Cash Flow | 24.59M | -41.38M | -53.67M |
| Capital Expenditures | -8.88M | -5.40M | -6.17M |
| Investing Cash Flow | -8.92M | -5.43M | 82.84M |
| Share Repurchases | 0 | -546.00K | 0 |
| Debt Issued | 0 | 49.77M | 15.00M |
| Debt Repaid | 0 | -35.00M | 0 |
| Financing Cash Flow | 288.82M | 141.02M | 13.40M |
| Net Change in Cash | 304.50M | 94.21M | 42.57M |
| Free Cash Flow | 15.71M | -46.78M | -59.85M |
This table shows 3 annual periods of BillionToOne's cash flow statement, from FY 2025 back to FY 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BLLN's reporting calendar. What is a cash flow statement?